切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - Pyruvate dehydrogenases (PDH) - angiogenesis - Inward Rectifier Potassium (Kir) Channels - PD-1/PD-L1 interaction

10 件产品

每页
清除全部
  1. PD-1/PD-L1 inhibitor 2
    B6023 PD-1/PD-L1 inhibitor 2
    Target: PD-1/PD-L1 interaction
    Summary: PD-1/PD-L1相互作用的抑制剂
      ≥42 mg/mL
      insoluble in H2O
  2. FG2216
    B5851 FG2216
    Target: Pyruvate dehydrogenases (PDH)
    Summary: HIF-脯氨酰羟化酶抑制剂
      ≥14.05 mg/mL
      insoluble in H2O
  3. Nateglinide
    B2198 Nateglinide
    中文名: 那格列奈
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 胰岛素促分泌剂
      ≥16.4 mg/mL
      insoluble in H2O
  4. Gliclazide
    B2195 Gliclazide
    中文名: 格列齐特
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 钾通道抑制剂
      ≥15.6 mg/mL
      insoluble in H2O
  5. Mitiglinide Calcium
    B2193 Mitiglinide Calcium
    中文名: 米格列奈钙
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 钾通道抑制剂
      ≥33.45 mg/mL
      insoluble in H2O
  6. Glibenclamide
    B1296 Glibenclamide
    中文名: 格列本脲
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 胰岛素生产调节剂
      ≥49.4 mg/mL
      insoluble in H2O
  7. Terfenadine
    A8534 Terfenadine
    中文名: 特非那定
    Target: Voltage-gated Potassium (KV) Channels|Histamine H1 Receptors|Inward Rectifier Potassium (Kir) Channels
    Summary: 组胺H1受体拮抗剂
      ≥18 mg/mL
      insoluble in H2O
  8. CPI-613
    A4333 CPI-613
     1 Citation
    Target: Pyruvate dehydrogenases (PDH)
    Summary: PDH/α-KGDH抑制剂
      ≥19.45 mg/mL
      insoluble in H2O
  9. Lenalidomide (CC-5013)
    A4211 Lenalidomide (CC-5013)
    中文名: 来那度胺
    Target: angiogenesis
    Summary: 抗肿瘤药物,抑制血管生成。
      ≥100.8 mg/mL
      insoluble in H2O
  10. Glimepiride
    A4033 Glimepiride
    中文名: 格列美脲
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 磺酰脲类化合物
      ≥21.45 mg/mL
      insoluble in H2O

10 件产品

每页